Abstract
The current paper is a commentary on the Metabolic reprogramming‐associated genes predict overall survival for rectal cancer (Jian‐Qing Lin et al 2020). The authors concluded that ‘Patients with high‐risk demonstrated significantly poorer survival outcomes than patients with low‐risk in the TCGA database. Also, patients with high‐risk still showed significantly poorer survival outcomes than patients with low‐risk in the GEO database’. But the figure 3 in their published paper, ‘Survival analyses for the prognostic metabolic genes in rectal cancer’, presented that there was type I error in their study during the hypothesis testing process, obviously.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
